Lipidomic Analysis Reveals Differences in the Extent of Remyelination in the Brain and Spinal Cord
Year: 2023
Type: article
Abstract: ABSTRACT During demyelination, lipid-rich myelin debris is released in the central nervous system (CNS) and must be phagocytosed and processed before new myelin can form. Although myelin comprises over 70% lipids, relatively little is known about how the CNS lipidome changes during demyelination and remyelination. In this study, we obtained a longitudinal lipidomic profile of the brain, spinal cord, and serum using a genetic mouse model of demyelination, known as Plp1 -iCKO- Myrf mice. This model has distinct phases of demyelination and remyelination over the course of 24 weeks, in which loss of motor function peaks during demyelination. Using principal component analysis (PCA) and volcano plots, we have demonstrated that the brain and spinal cord have different remyelination capabilities and that this is reflected in different lipidomic profiles over time. We observed that plasmalogens (ether-linked phosphatidylserine and ether-linked phosphatidylcholine) were elevated specifically during the early stages of active demyelination. In addition, we identified lipids in the brain that were altered when mice were treated with a remyelinating drug, which may be CNS biomarkers of remyelination. The results of this study provide new insights into how the lipidome changes in response to demyelination, which will enable future studies to elucidate mechanisms of lipid regulation during demyelination and remyelination.
Source: Journal of Proteome Research
Institution: University of Kansas
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: National Science Foundation, U.S. Department of Agriculture, American Thyroid Association, University of Kansas, National Institutes of Health, National Institute of Food and Agriculture, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Chemistry
Awards: G1262097396, National Metabolomics Data Repository - nextgen Metabolomics Workbench, REU Site: A Summer Experience for Undergraduates Integrating Research, Education, and Career Development in an Interdisciplinary Environment, G3823147841, Biomedical Data Commons Workbench (BDCW), MRI: Acquisition of an electrospray ionization triple quadrupole mass spectrometer with ion mobility spectrometry for improved plant lipidomics, Metabolomics Consortium Coordinating Center (M3C), Molecular Analysis of Disease Pathways, G8066140875, G8580555148, G881351143, Kansas IDeA Network of Biomedical Research Excellence 5, Molecular Analysis of Disease Pathways
OpenAlex ID: W4389138031
